Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Oral Abstract PresentationsSession Title: Concurrent XIV C: Inflammation, Immunity and Cytokines II

Abstract 071: CX3CR1 Deficiency Aggravates Renal Damage in Angiotensin II Induced Hypertensive Kidney Injury

Ulrich Wenzel, Erfan Ahzdahan, Hajo Paust, Christian Kurts, Alva Rosendahl
Hypertension. 2015;66:A071
Ulrich Wenzel
Univ Hosp of Hamburg, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erfan Ahzdahan
Univ Hosp of Hamburg, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hajo Paust
Univ Hosp of Hamburg, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Kurts
Institute of Molecular Medicine and Experimental Immunology, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alva Rosendahl
Univ Hosp of Hamburg, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
  • Info & Metrics
  • eLetters
Loading

Abstract

A dense network of macrophages and dendritic cells (DCs) expressing the chemokine receptor CX3CR1 populates the kidney. We recently reported that CX3CR1 regulates the abundance of DCs selectively in the kidney and promotes renal inflammation in glomerulonephritis. Given that inflammation plays also an important role in hypertensive renal injury, we hypothesized that CX3CR1 deficiency should attenuate renal injury in hypertension by reducing the number of renal DCs.

Renal injury was induced by unilateral nephrectomy, angiotensin II (Ang II) infusion (1.5 ng/min/g) and salt (0.9% drinking water).

Ang II induced heavy proteinuria (measured as albumin/creatinine ratio in mg/mg) compared to controls (0.1±0.0) and proteinuria was unexpectedly more severe in knockout mice than in wildtype (WT) mice (day 3 after of Ang II infusion: 19.2±5.4 vs. 2.5±0.6 p<0.01, day 14: 32.4±8.5 vs. 9.2±2.6 p<0.05 n=13 and 11 respectively). Histologic evaluation of kidney sections revealed also an increased number of proteinaceous casts and more glomerular injury in knockout mice (casts 1.1±0.3 vs. 0.1±0.1/high power field, glomerular injury score 0.95±0.06 vs. 0.57±0.06, p<0.01). Also plasma cholesterol levels were significantly higher in knockout mice than in WT mice (145±11 vs. 105±6 mg/dl, p<0.01). No difference was found for blood pressure and cardiac injury (hypertrophy, fibrosis, fetal gene expression) between both groups. Flow cytometric analysis revealed that Ang II infusion significantly increased the number of renal CD11c+/MHCII+ DCs in WT (38.5±1.4%, gated on CD45+ cells) compared to controls (31.8±3.6%, p<0.05). However, a significant decrease of renal DCs was found in hypertensive CX3CR1 deficient mice (15.2±1.5%, p<0.001). In contrast, the number of CD11bintermediate/F4/80high macrophages was 8 times higher in the kidney of CX3CR1 deficient mice compared to wildtype mice (5.5±1.5 vs.0.9±0.2%, p<0.01). These findings show that CX3CR1 deficiency reduces renal DC numbers and increases numbers of renal macrophages in hypertension. Surprisingly, despite reduced DC numbers, CX3CR1 deficiency increases proteinuria and glomerular injury, thus, CX3CR1 inhibition should be avoided in hypertension because it may promote proteinuria and renal injury.

  • Angiotensin II
  • dendritic cell
  • chemokines
  • Author Disclosures: U. Wenzel: None. E. Ahzdahan: None. H. Paust: None. C. Kurts: None. A. Rosendahl: None.

  • © 2015 by American Heart Association, Inc.
Back to top
Previous Article

This Issue

Hypertension
September 2015, Volume 66, Issue Suppl 1
  • Table of Contents
Previous Article

Jump to

  • Article
  • Info & Metrics

Article Tools

  • Citation Tools
    Abstract 071: CX3CR1 Deficiency Aggravates Renal Damage in Angiotensin II Induced Hypertensive Kidney Injury
    Ulrich Wenzel, Erfan Ahzdahan, Hajo Paust, Christian Kurts and Alva Rosendahl
    Hypertension. 2015;66:A071, originally published November 3, 2015

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Abstract 071: CX3CR1 Deficiency Aggravates Renal Damage in Angiotensin II Induced Hypertensive Kidney Injury
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Abstract 071: CX3CR1 Deficiency Aggravates Renal Damage in Angiotensin II Induced Hypertensive Kidney Injury
    Ulrich Wenzel, Erfan Ahzdahan, Hajo Paust, Christian Kurts and Alva Rosendahl
    Hypertension. 2015;66:A071, originally published November 3, 2015
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured